Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Detection of SARS-CoV-2 infection by saliva and nasopharyngeal sampling in frontline healthcare workers: An observational cohort study.

Walker NF. et al, (2023), PLoS One, 18

Practical considerations for a TB controlled human infection model (TB-CHIM); the case for TB-CHIM in Africa, a systematic review of the literature and report of 2 workshop discussions in UK and Malawi.

Gordon SB. et al, (2023), Wellcome Open Res, 8

Human Infection Challenge with Serotype 3 Pneumococcus.

Robinson RE. et al, (2022), Am J Respir Crit Care Med, 206, 1379 - 1392

Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial.

Shaw RH. et al, (2022), Lancet Respir Med, 10, 1049 - 1060

Airway-resident T cells from unexposed individuals cross-recognize SARS-CoV-2.

Diniz MO. et al, (2022), Nat Immunol

Airway-resident functional T cell responses against SARS-CoV-2 in unexposed individuals

Maini M. et al, (2022)

Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2.

Mitsi E. et al, (2022), J Clin Invest, 132

Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.

Stuart ASV. et al, (2022), Lancet, 399, 36 - 49

The influence of pneumococcal conjugate vaccine-13 on nasal colonisation in a controlled human infection model of pneumococcal carriage in Malawi: A double-blinded randomised controlled trial protocol

Morton B. et al, (2022)

AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein-specific TH1 response with a diverse TCR repertoire.

Swanson PA. et al, (2021), Sci Transl Med, 13

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection.

Feng S. et al, (2021), Nat Med, 27, 2032 - 2040

Microbiota and compartment matter in the COVID-19 response.

Jochems SP. et al, (2021), Nat Immunol, 22, 1350 - 1352

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.

Liu X. et al, (2021), Lancet, 398, 856 - 869

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.

Emary KRW. et al, (2021), Lancet, 397, 1351 - 1362

Experimental Human Pneumococcal Colonization in Older Adults Is Feasible and Safe, Not Immunogenic.

Adler H. et al, (2021), Am J Respir Crit Care Med, 203, 604 - 613

Pneumococcal colonization impairs mucosal immune responses to live attenuated influenza vaccine.

Carniel BF. et al, (2021), JCI Insight, 6

The influence of pneumococcal conjugate vaccine-13 on nasal colonisation in a controlled human infection model of pneumococcal carriage in Malawi: a double-blinded randomised controlled trial protocol.

Morton B. et al, (2021), Wellcome Open Res, 6

Upper airways colonisation of Streptococcus pneumoniae in adults aged 60 years and older: A systematic review of prevalence and individual participant data meta-analysis of risk factors.

Smith EL. et al, (2020), J Infect, 81, 540 - 548

Experimental human pneumococcal colonisation in older adults is feasible and safe, not immunogenic

Adler H. et al, (2020)

Symptoms associated with influenza vaccination and experimental human pneumococcal colonisation of the nasopharynx.

Hales C. et al, (2020), Vaccine, 38, 2298 - 2306

Load More

Include forthcoming?